Latest News
Decode Age Source Name: Decode Age

Promising Duo for Revolutionary Cancer Treatment: Resveratrol and Copper - Dr. Vishal Rao

Apr 04, 2024 16:22 IST 
Bangalore, Karnataka, India

In 2022, India faced a challenge, with over 14.1 lakh new cancer cases and more than 9.1 lakh deaths due to the disease. The risk of developing cancer before the age of 75 in India is calculated at 10.6%, with a mortality risk of 7.2%. These numbers are significantly high considering the population of India. The current treatment against cancer includes chemotherapy, which uses strong chemicals that target the cancer cells; immunotherapy, which boosts your body's natural defences; radiation therapy, which uses high-energy rays to eliminate the cancer cells; and surgery to remove the affected tissue. These treatments, while often effective in managing cancer, come with their own set of challenges, primarily due to the adverse effects they can have on patients. The physical and emotional toll of these side effects significantly impacts the quality of life of cancer patients.


Dr. Vishal Rao


A novel tablet combining the natural compounds resveratrol, a natural compound found in grapes and copper may provide a breakthrough solution. This unique synergy not only promises more precise and effective cancer treatments but also aims to reduce the adverse effects associated with traditional therapies, sparking a wave of optimism among the scientific community. By targeting the chromatin within cancer cells, this innovative formula could herald a new era in oncology, offering hope to millions worldwide affected by cancer. While the media buzz has generated palpable excitement, we must approach this promising development with an open yet discerning mindset. It also advocates for ongoing research and open dialogue to navigate this transformative period in cancer care adeptly. Let's understand this better:


The Dual Strategy: Eradication and Immunity Enhancement

In the relentless battle against cancer, the combination of resveratrol and copper presents a novel strategy that targets cell-free chromatin particles (cfChPs), known carriers of cancer-promoting genes. This innovative approach not only aims to eradicate cancer cells directly but also seeks to bolster the immune system's ability to identify and eliminate these malignant cells.


The Role of Resveratrol and Copper

Resveratrol, a compound celebrated for its antioxidant and anti-inflammatory properties since the 1970s, has emerged as a potent ally in cancer therapy. Found abundantly in grapes and red wine, resveratrol influences a wide range of molecular pathways, underscoring its potential as a versatile agent for cancer prevention and treatment. Research has demonstrated resveratrol's remarkable capacity to disrupt cancer progression at multiple stages, from the initial cell mutation to tumour growth and metastasis. Notably, resveratrol activates sirtuins, proteins intimately linked to ageing and DNA repair processes, inhibiting cancer cell proliferation and inducing apoptosis – a crucial mechanism for correcting the programmed cell death pathway often impaired in cancerous cells. Furthermore, resveratrol plays a pivotal role in enhancing the immune response by stimulating the production of anticancer cytokines and activating T cells, macrophages, and natural killer cells, which are instrumental in the body's defence against tumours. Resveratrol's ability to sensitise cancer cells to chemotherapy also addresses the critical challenge of drug resistance, making it a valuable component in comprehensive cancer treatment strategies.


Copper, revered in traditional medicine for its health benefits, contributes significantly to this synergistic approach by inducing oxidative stress in cancer cells, marking its therapeutic potential. Clinical trials have showcased the efficacy of the resveratrol-copper duo in diminishing the hallmarks of cancer, with findings pointing to cell-free chromatin from the tumour microenvironment as a primary instigator of these cancer hallmarks. This synergy between resveratrol and copper enhances oxidative stress and amplifies the anticancer effects. However, it is essential to note that the copper-to-resveratrol ratio used in these trials was approximately 1:1000, indicating that copper played an accessory role in enhancing the effects of resveratrol rather than being the primary element. The duo works together to activate the immune system, identify the DNA released from tumour cells, and target the cancer cells directly.


The Cautious Approach and The Path Forward

While resveratrol has been extensively studied as a nutraceutical and anti-ageing supplement, demonstrating tolerability in humans with minimal side effects, the concern centres on copper. In high concentrations, copper can induce oxidative stress, potentially exacerbating cancer risk. There needs to be a careful consideration of the complexities involved in cancer treatment and informed decision-making regarding supplement dosage and usage.


For more details please visit:

Dr. Vishal Rao
Dr. Vishal Rao
For press background on Decode Age

click here
Social Media Links